Specialty Pharmaceuticals Market, by Country(US, UK, France, Germany, Italy, Spain, Japan, South Korea), Application, Company, Global Analysis
Get Free Customization in This Report
Specialty pharmaceuticals are regarded to be a drug molecule that helps in the treatment of particular genetic conditions that have no therapeutic action on the market. Specialty Pharmaceuticals considered to be more targeted drugs than traditional drugs and are also less toxic. Specialty pharmaceutical consists of products like blood-derived, biopharmaceuticals, and complex molecules. Specialty pharmaceuticals are high cost and complex drugs; the average price per patient per year for specialty medical therapy is about $35,000 to $75,000. Specialty pharmaceutical is used to treat rare diseases such as Hepatitis C, Cancer, Rheumatoid Arthritis, AIDS (Acquired Immunodeficiency Virus Syndrome), Crohn’s disease, etc. Global Specialty Pharmaceuticals Market is expected to be USD 568 Billion by 2026.
Specialty pharmacy is multiplying and becoming a significant factor for health systems and producers across the United States. The FDA approved 21 new molecular entities in the second half of 2018. Out of these products, 12 (57%) are regarded pharmaceutical specialties based on variables such as indication and designed use population, administrative and tracking considerations, price and/or restricted delivery procedures. In the last five years, United States spending on specialty drugs has almost doubled.
Renub Research report titled “Specialty Pharmaceuticals Market, by Country (United States, United Kingdom, France, Germany, Italy, Spain, Japan, South Korea), Application (Oncology, Autoimmune, Immunology, HIV, Multiple Sclerosis, Viral Hepatitis, Blood Coagulation, Respiratory, Osteoporosis, Others), Company (Teva Pharmaceutical, CVS Health, Endo International, UnitedHealth Group Incorporated, Recordati Pharmaceuticals) Global Analysis” provides a complete analysis of Global Specialty Pharmaceutical Market.
Oncology, Autoimmune, and Immunology are among the most significant application of global specialty pharmaceutical market
The report studies the market of the following application segments: Oncology, Autoimmune, Immunology, HIV, Multiple Sclerosis, Viral Hepatitis, Blood Coagulation, Respiratory, Osteoporosis and Others. Due to the rising cases of oncology globally, Oncology is the leading application segment in this market place.
Specialty Pharmaceutical Market Share is expected to cross half of the global pharmaceutical market
Global pharmaceutical market is segmented by two types: traditional pharmaceutical and specialty pharmaceutical. At present, traditional pharmaceutical is in the dominating position across the globe, but due to increasing demands of specialty pharmaceutical products, it is anticipated that specialty pharmaceuticals will lead during the forecast period.
Company Analysis
Teva Pharmaceutical, CVS Health, Endo International, UnitedHealth Group Incorporated, Recordati Pharmaceuticals are some of the companies that deal efficiently in the specialty pharmaceuticals business. These companies have been studied thoroughly in the report.
Global Specialty Pharmaceutical Market – By Country
• United States
• United Kingdom
• France
• Germany
• Italy
• Spain
• Japan
• South Korea
Global Specialty Pharmaceutical Market – By Application
• Oncology
• Autoimmune
• Immunology
• HIV
• Multiple Sclerosis
• Viral Hepatitis
• Blood Coagulation
• Respiratory
• Osteoporosis and
• All Others
Global Pharmaceutical Market – By Segments
• Global
• Traditional
• Specialty
Global Specialty Pharmaceutical Market – Company Covered
• Teva Pharmaceutical
• CVS Health
• Endo International
• UnitedHealth Group Incorporated
• Recordati Pharmaceuticals
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at info@renub.com
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Global Specialty Pharmaceuticals
4.1 Market
4.2 Specialty Drug Pipeline
5. Market Share – Specialty Pharmaceutical Analysis
5.1 By Country
5.2 By Pharmaceutical Industry
5.3 By Application
6. Global Pharmaceuticals Analysis
6.1 Total Market
6.2 Traditional Pharmaceutical Market
7. Country – Specialty Pharmaceutical
7.1 United States
7.1.1 Market
7.1.2 Specialty Drug Pipeline
7.2 Top 5 European Country
7.2.1 Market
7.2.2 Specialty Drug Pipeline
7.3 United Kingdom
7.3.1 Market
7.3.2 Specialty Drug Pipeline
7.4 France
7.4.1 Market
7.4.2 Specialty Drug Pipeline
7.5 Germany
7.5.1 Market
7.5.2 Specialty Drug Pipeline
7.6 Italy
7.6.1 Market
7.6.2 Specialty Drug Pipeline
7.7 Spain
7.7.1 Market
7.7.2 Specialty Drug Pipeline
7.8 Japan
7.8.1 Market
7.8.2 Specialty Drug Pipeline
7.9 South Korea
7.9.1 Market
7.9.2 Specialty Drug Pipeline
8. Application – Specialty Pharmaceutical Market
8.1 Oncology
8.2 Autoimmune
8.3 Immunology
8.4 HIV
8.5 Multiple Sclerosis (MS)
8.6 Viral Hepatitis
8.7 Blood Coagulation
8.8 Respiratory
8.9 Osteoporosis
8.10 All Others
9. Market Dynamics
9.1 Growth Drivers
9.1.1 Improving Life Expectancy
9.1.2 Surge in Spending on Medicines
9.1.3 Prevalence of Chronic Disease
9.2 Key Challenges
9.2.1 Abandonment Rates for Specialty Medicines & High R&D Costs
10. Trend and Opportunities
10.1 Trends
10.1.1 Increased Spending on Specialty Pharmacy
10.1.2 A Generic Wave of Specialty Drugs
10.1.3 An Ever-expanding Pipeline of Products
10.1.4 Targeted Therapies to Emerge
10.1.5 Healthcare Reforms to Take Control
10.1.6 Growth of Co-Pay Programs
10.1.7 Medication Therapy Management (MTM) will Advance
10.1.8 Specialty Prescribing to Rise
10.1.9 Real-Time Pharmacy Benefit
10.2 Opportunities
10.2.1 Leverage the Changing Face of Specialty Pharmacy Industry with Flat world Solutions
11. Specialty Pharmacy Mergers and Acquisitions
12. Company Analysis
12.1 Teva Pharmaceutical Industries Ltd
12.1.1 Overview
12.1.2 Recent Developments
12.1.3 Revenue
12.2 CVS Health
12.2.1 Overview
12.2.2 Recent Developments
12.2.3 Revenue
12.3 Endo International Specialty Products
12.3.1 Overview
12.3.2 Recent Developments
12.3.3 Revenue
12.4 UnitedHealth Group Incorporated
12.4.1 Overview
12.4.2 Recent Developments
12.4.3 Revenue
12.5 Recordati Pharmaceuticals Ltd
12.5.1 Overview
12.5.2 Recent Developments
12.5.3 Revenue
13. Conclusion
List of Figures:
Figure-01: Global - Specialty Market (Million US$), 2015 – 2018
Figure-02: Global - Forecast For Specialty Market (Million US$), 2019 – 2026
Figure-03: Global - Pharmaceutical Market Share By Segment (Percent), 2015 – 2018
Figure-04: Global - Forecast for Pharmaceutical Market Share By Segment (Percent), 2019 – 2026
Figure-05: Global - Pharmaceutical market (Million US$), 2015 – 2018
Figure-06: Global - Pharmaceutical Forecast for market (Million US$), 2019 – 2026
Figure-07: Global - Traditional Pharmaceutical Market (Million US$), 2015 – 2018
Figure-08: Global - Forecast For Traditional Pharmaceutical Market (Million US$), 2019 – 2026
Figure-09: United States - Specialty Pharmaceutical market (Million US$), 2015 – 2018
Figure-10: United States - Forecast For Specialty Pharmaceutical market (Million US$), 2019 – 2026
Figure-11: Top 5 European Countries - Specialty Pharmaceutical market (Billion US$) 2015 - 2018
Figure-12: Top 5 European Countries – Forecast for Specialty Pharmaceutical market (Billion US$) 2019 - 2026
Figure-13: United Kingdom - Specialty Pharmaceutical market (Million US$), 2015 – 2018
Figure-14: United Kingdom – Forecast for Specialty Pharmaceutical market (Million US$), 2019 – 2026
Figure-15: France - Specialty Pharmaceutical market (Million US$), 2015 – 2018
Figure-16: France - Forecast For Specialty Pharmaceutical market (Million US$), ) 2019 – 2026
Figure-17: Germany - Specialty Pharmaceutical market (Million US$), 2015 – 2018
Figure-18: Germany - Forecast For Specialty Pharmaceutical market (Million US$), 2019 – 2026
Figure-19: Italy - Specialty Pharmaceutical market (Million US$), 2015 – 2018
Figure-20: Italy - Forecast For Specialty Pharmaceutical market (Million US$), 2019 – 2026
Figure-21: Spain - Specialty Pharmaceutical market (Million US$), 2015 – 2018
Figure-22: Spain - Forecast For Specialty Pharmaceutical market (Million US$), 2019 – 2026
Figure-23: Japan - Specialty Pharmaceutical market (Million US$), 2015 – 2018
Figure-24: Japan - Forecast For Specialty Pharmaceutical market (Million US$), 2019 – 2026
Figure-25: South Korea - Specialty Pharmaceutical market (Million US$), 2015 – 2018
Figure-26: South Korea - Forecast For Specialty Pharmaceutical market (Million US$), 2019 – 2026
Figure-27: By Application - Oncology Market (Million US$), 2015 – 2018
Figure-28: Forecast For by Application Oncology Market (Million US$), 2019 – 2026
Figure-29: Application - Autoimmune Market (Million US$), 2015 – 2018
Figure-30: Application - Forecast for Autoimmune Market (Million US$), 2019 – 2026
Figure-31: Application - Immunology Market (Million US$), 2015 – 2018
Figure-32: Application - Forecast for Immunology Market (Million US$), 2019 – 2026
Figure-33: Application - Human Immunodeficiency Virus Market (Million US$), 2015 – 2018
Figure-34: Application - Forecast for Human Immunodeficiency Virus Market (Million US$), 2019 – 2026
Figure-35: By Application - Multiple Sclerosis (MS) Market (Million US$), 2015 – 2018
Figure-36: Forecast For by Application - Multiple Sclerosis (MS) Market (Million US$), 2019 – 2026
Figure-37: Application - Viral Hepatitis Market (Million US$), 2015 – 2018
Figure-38: Application - Forecast for Viral Hepatitis Market (Million US$), 2019 – 2026
Figure-39: Application - Blood Coagulation Market (Million US$), 2015 – 2018
Figure-40: Application - Forecast for Blood Coagulation Market (Million US$), 2019 – 2026
Figure-41: Application - Respiratory Market (Million US$), 2015 – 2018
Figure-42: Application - Forecast for Respiratory Market (Million US$), 2019 – 2026
Figure-43: Application - Osteoporosis Market (Million US$), 2015 – 2018
Figure-44: Application - Forecast for Osteoporosis Market (Million US$), 2019 – 2026
Figure-45: Application - All Others Market (Million US$), 2015 – 2018
Figure-46: Application - Forecast for All Others Market (Million US$), 2019 – 2026
Figure-47: Percentage of Global R&D Spending - by Pharma Companies
Figure-48: Teva Pharmaceutical Industries Ltd - Revenue (Million US$), 2014 – 2018
Figure-49: Teva Pharmaceutical Industries Ltd - Forecast For Revenue (Million US$), 2019 – 2026
Figure-50: CVS Health Revenue Market (Million US$), 2014 – 2018
Figure-51: Forecast For CVS Health Revenue Market (Million US$), 2019 – 2026
Figure-52: Endo International Specialty Products - Revenue (Million US$), 2014 – 2018
Figure-53: Endo International Specialty Products - Forecast For Revenue (Million US$), 2019 – 2026
Figure-54: UnitedHealth Group Incorporated - Revenue (Million US$), 2014 – 2018
Figure-55: UnitedHealth Group Incorporated - Forecast For Revenue (Million US$), 2019 – 2026
Figure-56: Recordati Pharmaceuticals Ltd - Revenue (Million US$), 2014 – 2018
Figure-57: Recordati Pharmaceuticals Ltd - Forecast For Revenue (Million US$), 2019 – 2026
List of Tables:
Table-01: Global Specialty Drug Pipeline
Table-02: Global - Specialty Pharmaceutical Market Share By Country (Percent), 2015 – 2018
Table-03: Global - Forecast For Specialty Pharmaceutical Market Share By Country (Percent), 2019 – 2026
Table-04: Global - Specialty Pharmaceutical Market Share By Application (Percent), 2015 – 2018
Table-05: Global - Forecast for Specialty Pharmaceutical Market Share By Application (Percent), 2019 – 2026
Table-06: United States – Companies Specialty Drug/R&D Pipeline
Table-07: Shire Specialty Drug Pipeline
Table-08: Meldex international Clinical Trial
Table-09: Therapeutics: focus on the Italian pipeline
Table-10: Orphan Drugs and Advanced Therapies
Table-11: Bioneer Corporation - Research & Development Pipeline
Table-12: CORESTEM Inc - Research & Development Pipeline of
Table-13: Crystal Genomics, Inc - Research & Development Pipeline
Table-14: Genexine - Research & Development Pipeline
Table-15: ViroMed Co. – Representative Product – Biologics (Clinical Trial)
Table-16: Bcworld Pharm. Co., Ltd. – Main Products
Table-17: Bcworld Pharm. Co., Ltd – R&D Pipeline
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com